Vascular Normalization: A New Window Opened for Cancer Therapies
Preclinical and clinical antiangiogenic approaches, with multiple side effects such as resistance, have not been proved to be very successful in treating tumor blood vessels which are important targets for tumor therapy. Meanwhile, restoring aberrant tumor blood vessels, known as tumor vascular norm...
Main Authors: | Ting Yang, Hongqi Xiao, Xiaoxia Liu, Zhihui Wang, Qingbai Zhang, Nianjin Wei, Xinggang Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.719836/full |
Similar Items
-
Tumor Endothelial Cell—A Biological Tool for Translational Cancer Research
by: Dorcas Akuba-Muhyia Annan, et al.
Published: (2020-05-01) -
Involvement of Extracellular Vesicles in Vascular-Related Functions in Cancer Progression and Metastasis
by: Shinsuke Kikuchi, et al.
Published: (2019-05-01) -
Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?
by: George Mattheolabakis, et al.
Published: (2019-11-01) -
Antiangiogenic effect of betamethasone on the chick cam stimulated by TA3 tumor supernatant
by: DAVID LEMUS, et al.
Published: (2001-01-01) -
Effect of microRNA-155 on the pathogenesis of primary open angle glaucoma
by: Ru-Fei Yang, et al.
Published: (2018-05-01)